Vioxx also known as Rofecoxib was a drug widely used for arthritis. Merck, the pharmaceutical company responsible for making, marketing and distributing the drug to treat osteoarthritis, acute pain conditions, and dysmenorrhoea voluntarily pulled their drug off the market due to previously known scientific studies revealing the drug doubled the risk of heart attack and stroke with a wide range of injuries including death.

Merck launched Vioxx in 1999 and brought in revenues in excess of 10 billion dollars.

Branch Law Firm is at the forefront of the Vioxx litigation and has worked tirelessly to maximize our clients’ compensation. We have secured settlements for hundreds of clients across the country who were injured by Vioxx. At the Branch Law Firm we continue our leadership role in our aggressive action against Merck which resulted in satisfactory settlements for hundreds. Attorney Turner W. Branch is a special admittee to the New Jersey State bar, where all Vioxx litigation and settlements occurred. He was also appointed to the New Jersey Litigation Group by Judge Carol Higbee along with being on the Vioxx Trial Committee for preparation and discovery. Through the efforts of our experienced attorneys and hard working support staff Merck agreed to pay 4.85 billion dollars to settle all claims for injuries caused by the drug Vioxx.

For more information about Vioxx (Rofecoxib) please click on the link below:

FDA: Vioxx Safety Information